Biomarin Pharmaceutical Inc (BMRN)
66.04
-0.56
(-0.84%)
USD |
NASDAQ |
Nov 04, 12:55
Biomarin Pharmaceutical Debt to Equity Ratio: 0.1098 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.1098 |
| June 30, 2024 | 0.206 |
| March 31, 2024 | 0.2144 |
| December 31, 2023 | 0.2195 |
| September 30, 2023 | 0.2218 |
| June 30, 2023 | 0.2269 |
| March 31, 2023 | 0.2327 |
| December 31, 2022 | 0.2353 |
| September 30, 2022 | 0.2368 |
| June 30, 2022 | 0.24 |
| March 31, 2022 | 0.246 |
| December 31, 2021 | 0.253 |
| September 30, 2021 | 0.2527 |
| June 30, 2021 | 0.2539 |
| March 31, 2021 | 0.2586 |
| December 31, 2020 | 0.2618 |
| September 30, 2020 | 0.3573 |
| June 30, 2020 | 0.4459 |
| March 31, 2020 | 0.2632 |
| December 31, 2019 | 0.2716 |
| September 30, 2019 | 0.2744 |
| June 30, 2019 | 0.2834 |
| March 31, 2019 | 0.2843 |
| December 31, 2018 | 0.2798 |
| September 30, 2018 | 0.4118 |
| Date | Value |
|---|---|
| June 30, 2018 | 0.413 |
| March 31, 2018 | 0.4214 |
| December 31, 2017 | 0.4182 |
| September 30, 2017 | 0.4144 |
| June 30, 2017 | 0.2419 |
| March 31, 2017 | 0.2495 |
| December 31, 2016 | 0.247 |
| September 30, 2016 | 0.2554 |
| June 30, 2016 | 0.3495 |
| March 31, 2016 | 0.2917 |
| December 31, 2015 | 0.2759 |
| September 30, 2015 | 0.2913 |
| June 30, 2015 | 0.2807 |
| March 31, 2015 | 0.2703 |
| December 31, 2014 | 0.4208 |
| September 30, 2014 | 0.4355 |
| June 30, 2014 | 0.4452 |
| March 31, 2014 | 0.453 |
| December 31, 2013 | 0.4888 |
| September 30, 2013 | 0.0613 |
| June 30, 2013 | 0.0873 |
| March 31, 2013 | 0.0879 |
| December 31, 2012 | 0.3428 |
| September 30, 2012 | 0.3431 |
| June 30, 2012 | 0.3482 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.1098
Minimum
Sep 2024
0.4459
Maximum
Jun 2020
0.2504
Average
0.243
Median
Debt to Equity Ratio Benchmarks
| Merck & Co Inc | 0.8671 |
| Bristol-Myers Squibb Co | 2.902 |
| Alnylam Pharmaceuticals Inc | 31.64 |
| Bioventus Inc | 2.539 |
| Moderna Inc | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 6.851B |
| Total Liabilities (Quarterly) | 1.438B |
| Shareholders Equity (Quarterly) | 5.413B |
| Current Ratio | 4.271 |
| Net Debt Paydown Yield | 0.73% |